Basilea Pharmaceutica AG (BSLN:SW) Annual Income Statement ()
BSLN:SW Quarterly Financials ()
Frequently Asked Questions About Basilea Pharmaceutica AG (BSLN:SW) Stock
Basilea Pharmaceutica AG's (BSLN:SW) last reported annual revenue was N/A.
Basilea Pharmaceutica AG's (BSLN:SW) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
Basilea Pharmaceutica AG's(BSLN:SW) is not profitable as of its last reported annual financials.
The net profit margin for Basilea Pharmaceutica AG's(BSLN:SW) from its laster reported year is N/A
The return on equity (ROE) for Basilea Pharmaceutica AG's(BSLN:SW) from its last reported annual financials is : -4.10%
The return on assets (ROA) for Basilea Pharmaceutica AG's(BSLN:SW) from its last reported annual financials is : -2.05%
The return on invested capital (ROIC) for Basilea Pharmaceutica AG's(BSLN:SW) from its last reported annual financials is : 15.42%
The Debt to Equity ratio for Basilea Pharmaceutica AG's(BSLN:SW) from its last reported annual financials is : -954.26%
The dividend yield for Basilea Pharmaceutica AG's(BSLN:SW) from its laster reported year is 0.00%
Basilea Pharmaceutica AG's(BSLN:SW) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BSLN:SW !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
